Correlation Between Quoin Pharmaceuticals and NovaBay Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Quoin Pharmaceuticals and NovaBay Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quoin Pharmaceuticals and NovaBay Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quoin Pharmaceuticals Ltd and NovaBay Pharmaceuticals, you can compare the effects of market volatilities on Quoin Pharmaceuticals and NovaBay Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quoin Pharmaceuticals with a short position of NovaBay Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quoin Pharmaceuticals and NovaBay Pharmaceuticals.

Diversification Opportunities for Quoin Pharmaceuticals and NovaBay Pharmaceuticals

-0.08

Correlation Coefficient

Quoin Pharmaceuticals  NovaBay Pharmaceuticals

Good diversification

The 3 months correlation between Quoin and NovaBay is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Quoin Pharmaceuticals Ltd and NovaBay Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NovaBay Pharmaceuticals and Quoin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quoin Pharmaceuticals Ltd are associated (or correlated) with NovaBay Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NovaBay Pharmaceuticals has no effect on the direction of Quoin Pharmaceuticals i.e., Quoin Pharmaceuticals and NovaBay Pharmaceuticals go up and down completely randomly.

Pair Corralation between Quoin Pharmaceuticals and NovaBay Pharmaceuticals

Given the investment horizon of 90 days Quoin Pharmaceuticals Ltd is expected to under-perform the NovaBay Pharmaceuticals. In addition to that, Quoin Pharmaceuticals is 2.14 times more volatile than NovaBay Pharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. NovaBay Pharmaceuticals is currently generating about 0.11 per unit of volatility. If you would invest  59.00  in NovaBay Pharmaceuticals on October 11, 2024 and sell it today you would earn a total of  5.00  from holding NovaBay Pharmaceuticals or generate 8.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Quoin Pharmaceuticals Ltd  vs.  NovaBay Pharmaceuticals

Quoin Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

NovaBay Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NovaBay Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, NovaBay Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Quoin Pharmaceuticals and NovaBay Pharmaceuticals

The main advantage of trading using opposite Quoin Pharmaceuticals and NovaBay Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quoin Pharmaceuticals position performs unexpectedly, NovaBay Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBay Pharmaceuticals will offset losses from the drop in NovaBay Pharmaceuticals' long position.

The idea behind Quoin Pharmaceuticals Ltd and NovaBay Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.